Antibiotics in   United States

Overview In August 2024 United States' Antibiotics exports accounted up to $48.3M and imports accounted up to $46.2M, resulting in a positive trade balance of $2.08M. Between August 2023 and August 2024 the exports of United States'   Antibiotics have decreased by $-14.2M (-22.8%) from $62.5M to $48.3M, while imports decreased by $-21.3M (-31.6%) from $67.5M to $46.2M.

Destinations In August 2024, Antibiotics were exported mostly to Panama ($30.6M), Spain ($6.22M), Italy ($2.37M), China ($1.9M), and United Kingdom ($1.78M), and were imported mostly from China ($24.5M), Croatia ($6.62M), Bulgaria ($4.78M), Denmark ($2.45M), and Spain ($1.79M).

Growth In August 2024, the decrease in Antibiotics's year-by-year exports was explained primarily by a decrease in exports to France ($-4.97M or -52.4%), China ($-1.73M or -68.7%), and Japan ($-526k or -45%). In August 2024, the decrease in Antibiotics's year-by-year imports was explained primarily by a decrease in imports from Japan ($-6.1M or -99.9%), Switzerland ($-2.58M or -99.2%), and Italy ($-2.04M or -49.1%).